Bacillus Calmette-Guerin therapy for upper urinary tract transitional cell carcinoma using a transvesical single-j stent

Ryoji Arata, Tomoyasu Tsushima, Yasutomo Nasu, Masaya Tsugawa, Koichi Monden, Shin Ebara, Hiromi Kumon

Research output: Contribution to journalArticle

Abstract

Two patients with upper urinary tract transitional cell carcinoma were treated with ureteroscopic tumor ablation followed by bacillus Calmette-Guerin (BCG) therapy. Prior to the BCG therapy, a single-J stent was inserted into the renal pelvis via the percutaneous transvesical route. A dose of 240mg BCG dissolved in 120ml normal saline was administered weekly for 6 weeks. No severe side effects were observed. Both patients were tumor-free at 9- (Case 1), and 27-month (Case 2) follow-up, respectively. Although BCG instillation into the upper urinary tract has been conducted using a percutaneous nephrostomy tube, a retrograde ureteral catheter, or an indwelling double-J stent creating artificial vesicoureteral reflux, it is considered that the present method is both simple and more reliable than other methods.

Original languageEnglish
Pages (from-to)30-34
Number of pages5
JournalNishinihon Journal of Urology
Volume64
Issue number1
Publication statusPublished - 2002

Fingerprint

Transitional Cell Carcinoma
Mycobacterium bovis
Urinary Tract
Stents
Percutaneous Nephrostomy
Urinary Catheters
Vesico-Ureteral Reflux
Kidney Pelvis
Therapeutics
Neoplasms

Keywords

  • BCG therapy
  • Transitional cell carcinoma
  • Upper urinary tract

ASJC Scopus subject areas

  • Urology

Cite this

Bacillus Calmette-Guerin therapy for upper urinary tract transitional cell carcinoma using a transvesical single-j stent. / Arata, Ryoji; Tsushima, Tomoyasu; Nasu, Yasutomo; Tsugawa, Masaya; Monden, Koichi; Ebara, Shin; Kumon, Hiromi.

In: Nishinihon Journal of Urology, Vol. 64, No. 1, 2002, p. 30-34.

Research output: Contribution to journalArticle

Arata, Ryoji ; Tsushima, Tomoyasu ; Nasu, Yasutomo ; Tsugawa, Masaya ; Monden, Koichi ; Ebara, Shin ; Kumon, Hiromi. / Bacillus Calmette-Guerin therapy for upper urinary tract transitional cell carcinoma using a transvesical single-j stent. In: Nishinihon Journal of Urology. 2002 ; Vol. 64, No. 1. pp. 30-34.
@article{24e05529649241819f43e1efc25434aa,
title = "Bacillus Calmette-Guerin therapy for upper urinary tract transitional cell carcinoma using a transvesical single-j stent",
abstract = "Two patients with upper urinary tract transitional cell carcinoma were treated with ureteroscopic tumor ablation followed by bacillus Calmette-Guerin (BCG) therapy. Prior to the BCG therapy, a single-J stent was inserted into the renal pelvis via the percutaneous transvesical route. A dose of 240mg BCG dissolved in 120ml normal saline was administered weekly for 6 weeks. No severe side effects were observed. Both patients were tumor-free at 9- (Case 1), and 27-month (Case 2) follow-up, respectively. Although BCG instillation into the upper urinary tract has been conducted using a percutaneous nephrostomy tube, a retrograde ureteral catheter, or an indwelling double-J stent creating artificial vesicoureteral reflux, it is considered that the present method is both simple and more reliable than other methods.",
keywords = "BCG therapy, Transitional cell carcinoma, Upper urinary tract",
author = "Ryoji Arata and Tomoyasu Tsushima and Yasutomo Nasu and Masaya Tsugawa and Koichi Monden and Shin Ebara and Hiromi Kumon",
year = "2002",
language = "English",
volume = "64",
pages = "30--34",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "1",

}

TY - JOUR

T1 - Bacillus Calmette-Guerin therapy for upper urinary tract transitional cell carcinoma using a transvesical single-j stent

AU - Arata, Ryoji

AU - Tsushima, Tomoyasu

AU - Nasu, Yasutomo

AU - Tsugawa, Masaya

AU - Monden, Koichi

AU - Ebara, Shin

AU - Kumon, Hiromi

PY - 2002

Y1 - 2002

N2 - Two patients with upper urinary tract transitional cell carcinoma were treated with ureteroscopic tumor ablation followed by bacillus Calmette-Guerin (BCG) therapy. Prior to the BCG therapy, a single-J stent was inserted into the renal pelvis via the percutaneous transvesical route. A dose of 240mg BCG dissolved in 120ml normal saline was administered weekly for 6 weeks. No severe side effects were observed. Both patients were tumor-free at 9- (Case 1), and 27-month (Case 2) follow-up, respectively. Although BCG instillation into the upper urinary tract has been conducted using a percutaneous nephrostomy tube, a retrograde ureteral catheter, or an indwelling double-J stent creating artificial vesicoureteral reflux, it is considered that the present method is both simple and more reliable than other methods.

AB - Two patients with upper urinary tract transitional cell carcinoma were treated with ureteroscopic tumor ablation followed by bacillus Calmette-Guerin (BCG) therapy. Prior to the BCG therapy, a single-J stent was inserted into the renal pelvis via the percutaneous transvesical route. A dose of 240mg BCG dissolved in 120ml normal saline was administered weekly for 6 weeks. No severe side effects were observed. Both patients were tumor-free at 9- (Case 1), and 27-month (Case 2) follow-up, respectively. Although BCG instillation into the upper urinary tract has been conducted using a percutaneous nephrostomy tube, a retrograde ureteral catheter, or an indwelling double-J stent creating artificial vesicoureteral reflux, it is considered that the present method is both simple and more reliable than other methods.

KW - BCG therapy

KW - Transitional cell carcinoma

KW - Upper urinary tract

UR - http://www.scopus.com/inward/record.url?scp=0036172604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036172604&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036172604

VL - 64

SP - 30

EP - 34

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 1

ER -